3386 — Cosmo Bio Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeMicro CapNeutral

Annual income statement for Cosmo Bio Co, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	8,092	9,231	9,553	9,340	10,037
Cost of Revenue
Gross Profit	3,152	3,659	3,441	3,250	3,329
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	7,340	8,183	8,766	8,794	9,770
Operating Profit	752	1,048	787	546	267
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	1,008	1,099	790	653	369
Provision for Income Taxes
Net Income After Taxes	701	769	552	462	270
Minority Interest
Net Income Before Extraordinary Items
Net Income	674	738	517	443	263
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	674	737	517	442	262
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	114	127	92.5	72.6	51.5
Dividends per Share